Audrey Kelly
Psychiatric/Mental Health · Toms River, NJNPI 1851308522
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 196 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) at 31.7% of the total. Among psychiatric/mental health clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 196 payments — averaging $29.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Teva Pharmaceuticals USA, Inc.$1K
- AbbVie$1K
- Johnson & Johnson$667
- Alkermes, Inc.$374
- Neurocrine Biosciences, Inc.$293
- plus $477 from 7 others
What the payments were for
- Food & beverage$5,59397%
- Education$1913%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 64 | $1,836 |
| Teva Pharmaceuticals USA, Inc. | 34 | $1,103 |
| AbbVie | 51 | $1,034 |
| Johnson & Johnson | 21 | $667 |
| Alkermes, Inc. | 5 | $374 |
| Neurocrine Biosciences, Inc. | 4 | $293 |
| E.r. Squibb & Sons, L.L.C. | 5 | $193 |
| Vanda Pharmaceuticals Inc. | 5 | $163 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| Atricure, Inc. | 1 | $19 |
| Indivior Inc. | 1 | $17 |
| Braeburn Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,785 in reported general payments places this provider in the 95th percentile of 1,212 psychiatric/mental health providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 124 | $389,296 |
| AristadaAripiprazole Lauroxil | 48 | $167,501 |
| Abilify MaintenaAripiprazole | 58 | $165,049 |
| VraylarCariprazine Hcl | 65 | $106,355 |
| Invega TrinzaPaliperidone Palmitate | 11 | $103,226 |
| VivitrolNaltrexone Microspheres | 50 | $98,881 |
| CaplytaLumateperone Tosylate | 43 | $75,380 |
| Austedo XrDeutetrabenazine | 13 | $73,483 |
| LybalviOlanzapine/Samidorphan Malate | 40 | $66,386 |
| JubliaEfinaconazole | 11 | $49,845 |
| MounjaroTirzepatide | 20 | $43,417 |
| BelsomraSuvorexant | 69 | $29,598 |
| XiidraLifitegrast | 12 | $25,932 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $23,146 |
| JardianceEmpagliflozin | 11 | $14,082 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Invega Trinza | $667 | $492,522135 claims |
| Alkermes, Inc.Aristada, Vivitrol, Lybalvi | $374 | $332,768138 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $40 | $165,04958 claims |
| AbbVieVraylar | $1,034 | $106,35565 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $1,836 | $75,38043 claims |
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $1,103 | $73,48313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,212 psychiatric/mental health providers in New Jersey.
Other psychiatric/mental health in Toms River
- Gregory CoramToms River$5K
- Ubong UdofiaMarlton$407K
- Anthony DimuraRed Bank$130K
- Amy PinsenNewton$111K
- Aaron SpectorMarlton$100K
- Fiorella ParadisiSparta$84K
- Diane BurtBridgeton$81K
- Alta ManessHackensack$75K
- Laura LeahySewell$41K
- Linda WinfulMontclair$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.